Zevra Therapeutics Share Price (NASDAQ: ZVRA)
$9.07
Last updated on
Check the interactive Zevra Therapeutics Stock chart to analyse performance
Zevra Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$8.97Today's High:$9.30
1.1%
Downside
Day's Volatility :3.55%
Upside
2.47%
- 52 Weeks Low:$6.1952 Weeks High:$13.16
31.75%
Downside
52 Weeks Volatility :52.96%
Upside
31.08%
Zevra Therapeutics Stock Returns
Zevra Therapeutics Inc Key Stats
Check Zevra Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Zevra Therapeutics Stock including INR - Dollar returns
The Zevra Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zevra Therapeutics investment value today
Current value as on today
₹1,29,531
Returns
₹29,531
(+29.53%)
Returns from Zevra Therapeutics Stock
₹24,247 (+24.25%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Zevra Therapeutics Stock
Analyst Recommendation on Zevra Therapeutics Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Zevra Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Zevra Therapeutics Share Price Target
What analysts predicted
Upside of 156.02%
Target:
$23.22
Current:
$9.07
Zevra Therapeutics share price target is $23.22, a slight Upside of 156.02% compared to current price of $9.07 as per analysts' prediction.
Zevra Therapeutics Stock Insights
Price Movement
In the last 1 month, ZVRA stock has moved down by -17.5%Increasing Revenue
Revenue is up for the last 4 quarters, 3.69M → 25.88M (in $), with an average increase of 43.8% per quarterIncreasing Net Profit
Netprofit is up for the last 3 quarters, -35.73M → 74.70M (in $), with an average increase of 578.7% per quarterZVRA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 51.3%ZVRA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 43.4%Price to Sales
ForZVRA every $1 of sales, investors are willing to pay $7.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Zevra Therapeutics Inc Financials
Zevra Therapeutics Technicals Summary
Sell
Neutral
Buy
Zevra Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Zevra Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -18.36% | 23.74% | 24.25% | 65.21% | 61.96% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 10.67 | 1.22 | 0.04 | -0.19 | NA | 2.13 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $522.1M | 61.96% | NA | 4.26% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Zevra Therapeutics Inc
Key Management of Zevra Therapeutics Inc
Important FAQs about investing in ZVRA Stock from India :
What is Zevra Therapeutics share price today?
Zevra Therapeutics share price today is $9.07 as on at the close of the market. Zevra Therapeutics share today touched a day high of $9.30 and a low of $8.97.
What is the 52 week high and 52 week low for Zevra Therapeutics share?
Zevra Therapeutics share touched a 52 week high of $13.16 and a 52 week low of $6.19. Zevra Therapeutics stock price today i.e. is closed at $9.07, lower by 31.08% versus the 52 week high.
How to invest in Zevra Therapeutics Stock (ZVRA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Zevra Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zevra Therapeutics Shares that will get you 0.1654 shares as per Zevra Therapeutics share price of $9.07 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Zevra Therapeutics Stock (ZVRA) from India?
Indian investors can start investing in Zevra Therapeutics (ZVRA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Zevra Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Zevra Therapeutics share’s latest price of $9.07 as on August 30, 2025 at 1:29 am IST, you will get 1.1025 shares of Zevra Therapeutics. Learn more about
fractional shares .
What are the returns that Zevra Therapeutics has given to Indian investors in the last 5 years?
Zevra Therapeutics stock has given 61.96% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%